Loading...
SOBI logo
SOBI
Swedish Orphan Biovitrum

Altuvoct Adoption And Gamifant Launches Will Unlock European Opportunities

Published
20 Nov 24
Updated
01 May 25
AnalystConsensusTarget's Fair Value
SEK 341.18
19.2% undervalued intrinsic discount
04 Sep
SEK 275.60
Loading
1Y
-14.9%
7D
2.8%

Author's Valuation

SEK 341.2

19.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates8

Shared on01 May 25
Fair value Decreased 5.38%

Read more

Shared on23 Apr 25
Fair value Decreased 0.014%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 0.92%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Increased 5.71%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Decreased 6.43%

Read more

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Increased 5.98%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Decreased 1.47%

Read more